Long-term follow-up for children from the TEMPO study
Part of Immune system & allergy, Infections clinical trials.
This study checks on children who already took part in the TEMPO study during their first year of life. It helps researchers understand how things turned out over time and uses your child’s earlier study information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child finished the last TEMPO study visit at 12 months
- You agree to let study staff share your contact details with a third party for study purposes
- You agree that data collected in TEMPO can be used for this follow-up study
- You sign a written consent form to join the follow-up study
- You (the parents) have a smartphone, tablet, or computer with internet access
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term check-up for children who were in the TREOCAPA trial. It follows their health and development for about 2 years after they were in the original study.
This study checks on children and young people 5 to 15 years after they finished an 18-month oral immunotherapy treatment for peanut, egg, or milk allergy. It helps researchers understand how their allergies and health are doing over the long term.
This study follows people with HIV and healthy volunteers over time to see how their health, immune system, and aging change. It aims to find ways to improve long-term care.
This study checks on people who had weight treatment as children to see how they are doing now and what health outcomes they have. It helps understand the long-term effects of childhood weight management.
This study looks at how a parent's phone use (often called 'technoference') might affect a young child's behavior and emotions. If you join, you'll answer online questions now and again after 6 months, and this information may help us understand how to support healthy development.
This study is a follow-up for children ages 5 to 14 who joined the earlier Glowing and Expecting research. It helps the team learn how things are going over time after that first study.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.